Biotech News
Uniquity Bio Appoints Will Kane as CEO
Uniquity Bio, a clinical-stage drug development company backed by Blackstone Life Sciences, has appointed Will Kane as its new President and Chief Executive Officer. The announcement follows the departure of co-founder and former CEO Brian Lortie in June 2025. The
15 July 2025